Back to Results
First PageMeta Content
Cardiology / Medicine / Brain natriuretic peptide / N-terminal prohormone of brain natriuretic peptide / Biology / Heart failure / Atrial natriuretic peptide / Cardiovascular disease / Ejection fraction / Peptide hormones / Anatomy / Biomarkers


Horizon Scanning Technology
Add to Reading List

Document Date: 2015-03-10 20:22:29

Open Document

File Size: 109,76 KB

Share Result on Facebook

City

Oxford / /

Company

PROBNP IMMUNOASSAY PURPOSE AND TARGET GROUP / Bayer / Maisel A. S. / Diagnostics Incorporated / Ball / Roche Diagnostics / USE Limited / /

Continent

Australia / /

Country

Australia / United Kingdom / New Zealand / /

Currency

AUD / USD / /

Event

FDA Phase / /

Facility

University of Adelaide / /

Holiday

Commonwealth Day of Australia / /

IndustryTerm

health technology / literature search / /

MedicalCondition

congestive heart failure / Ventricular Dysfunction / cardiomyopathy / disease / chronic heart failure / left ventricular dysfunction / cardiac failure / shortness of breath / shock / heart disease / chronic hypertension / myocardial infarction / injury / heart failure / hepatitis / /

Organization

University of Adelaide / Health Policy Advisory Committee on Technology / New York Heart Association / National Horizon Scanning Unit / THERAPEUTIC GOODS ADMINISTRATION / FDA / Commonwealth Copyright Administration / Department of Health / Australian Health Ministers’ Advisory Council / Medical Services Advisory Committee / Attorney General’s Department / Department of Public Health / Medicare / /

Person

Linda Mundy / Tracy Merlin / /

Position

Governor / /

Product

Biosite / Elecsys / Australia / /

ProgrammingLanguage

J / /

ProvinceOrState

South Australia / /

Region

South Australia / /

Technology

health technology / health technologies / ultrasound / /

URL

http /

SocialTag